societ

Education

Certificate in Applied Biostatistics 2015

University of Washington: Seattle, Washington

Post-Graduate Year Two (PGY-2) Infectious Diseases Pharmacy Residency 2012-2013

West Virginia University Healthcare: Morgantown, West Virginia

Director: Douglas Slain, PharmD, BCPS-AQ ID, FASHP, FCCP

Post-Graduate Year One (PGY-1) Pharmacy Residency 2011-2012

West Virginia University Healthcare: Morgantown, West Virginia

Director: Justin Hare, PharmD

Doctor of Pharmacy 2008-2011

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

Bachelor of Science in Neuroscience 2001-2007

Brigham Young University: Provo, Utah

Professional Experience

Clinical Pharmacist July 2014-present

Tuality Healthcare: Hillsboro, Oregon

Infectious Diseases Clinical Specialist October 2013-present

Legacy Health: Portland, Oregon

Clinical Pharmacist July 2011-July 2013

West Virginia University Healthcare: Morgantown, West Virginia

Pharmacy Intern August 2009-March 2011

Erie Veterans Affairs Medical Center: Erie, Pennsylvania

Academic Appointments

Co-director of the Office of Educational Research and Statistics 2015-present

Pacific University, School of Pharmacy: Hillsboro, Oregon

Assistant Professor 2013-present

Pacific University, School of Pharmacy: Hillsboro, Oregon

Clinical Lecturer 2014-2016

Pacific University, School of Physician Assistant Studies: Hillsboro, Oregon

Adjunct Clinical Faculty 2011-2013

West Virginia University School of Pharmacy: Morgantown, West Virginia

Graduate Laboratory Manager 2010

Laboratory of Clinical and Experimental Toxicology

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

R. BRIGG TURNER, PHARMD, BCPS-AQ ID 222 SE 8th Ave Suite 451

Hillsboro, OR 97123 brigg.turner@pacificu.edu

2

Graduate Research Assistant 2008-2010

Laboratory of Clinical and Experimental Toxicology

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

Board Certification

Board Certified Pharmacotherapy Specialist with 2017-present

Added Qualifications in Infectious Diseases

Board Certified Pharmacotherapy Specialist (BCPS) 2013-present

Board of Pharmaceutical Specialties #3132091

Publications (Peer-Reviewed Journals)

Klepser ME, Dobson EL, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, Turner RB, Su CP, Jacobs DM, Suda

KJ. A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc (2003);2017, epub ahead of print.

Dobson EL, Klepser ME, Pogue JM, Labreche MJ, Adams AJ, Gauthier TP, Turner RB, Su CP, Jacobs DM, Suda

KJ. Outpatient antibiotic stewardship: interventions and opportunities. J Am Pharm Assoc (2003);2017, epub

ahead of print.

Turner RB, Valcarlos E, Loeffler AM, Gilbert M, Chan D. Impact of an antimicrobial stewardship program on

antibiotic use at a non-freestanding children’s hospital. J Pediatric Infect Dis Soc 2016;

https://doi.org/10.1093/jpids/piw059; epub ahead of print.

Hughes K, Lalikian KA, Schwartz J, Turner RB. Are proton pump inhibitors associated with an increased risk

of Clostridium difficile infection after considering confounding variables? J Hosp Infect 2017;95(4):445-446.

Stamper BD, Buhler AV, Harrelson JP, Robers SC, Malhotra A, Elbarbry FA, Rao D, Karimi R, Turner RB,

Marlow C, Devaud L. Forecasting academic success through implementation of an online prerequisite review

tutorials program for first year pharmacy students. Curr Pharm Teach Learn 2017;9(2):261-271.

Abdelkawy KS, Donia AM, Turner RB, Elbarbry F. Effects of Lemon and Seville Orange Juices on the

Pharmacokinetic Properties of Sildenafil in Healthy Subjects. Drugs R D 2016;16:271-278.

Turner RB, Valcarlos C, Won R, Chang E, Schwartz J. Impact of infectious diseases consultation on clinical

outcomes of patients with Staphylococcus aureus bacteremia at a community health system. Antimicrob

Agents Chemother 2016;60:5682-5687.

Bath S, Lines J, Loeffler AM, Malhotra A, Turner RB. Impact of standardization of antimicrobial prophylaxis

duration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2016;152:1115-1120.

Turner RB, Cumpston A, Sweet M, Briggs F, Slain D, Wen S, Craig M, Hamadani M, Petros W. A prospective,

controlled study of acyclovir pharmacokinetics in obese patients. Antimicrob Agents Chemother

2016;60(3):1830-1833.

Turner RB, Rouse S, Elbarbry F, Wanek S, Grover V, Chang E. Azithromycin pharmacokinetics in adults with

acute respiratory distress syndrome undergoing treatment with extracorporeal-membrane oxygenation. Ann

Pharmacother 2016;50:72-73.

Turner RB, Elbarbry F, Biondo L. Pharmacokinetics of once and twice daily dosing of intravenous tobramycin

in paediatric patients with cystic fibrosis. J Chemother 2015;28:304-307.

Turner RB, Martello JL, Malhotra A. Worsening renal function in patients with baseline renal impairment

treated with intravenous voriconazole: A systematic review. Int J Antimicrob Agents 2015;46:362-366.

Turner RB, Slain D, Petros K, Keller LA, Sarwari AR. Clinical outcomes following hospital-wide

implementation of prolonged-infusion cefepime and ceftazidime. Int J Antimicrob Agents 2015;46:129-30.

3

Bolus J, Turner RB. Prolonged-infusion dosing of beta-lactam antibiotics. US Pharm 2015;40(4):HS19-23.

Turner RB, Grover A, Malhotra A. The Clinical Management of Pancreatic Cancer. US Pharm 2014;39(9,

Supp):8-11.

Turner RB, Smith CB, Martell JL, Slain D. Role of doxycycline in Clostridium difficile infection acquisition. Ann

Pharmacother 2014;48:772-6.

Turner RB, Vagula M, Devi SS. Osteoporosis: an understated complication of diabetes. U.S. Pharm 2009; 34(5

supp):14-16.

Publications (Non-Peer-Reviewed Journals)

Turner RB, Slain D. Colistin Dosing: What is the Current Approach? Making a Difference in Infectious

Diseases Pharmacotherapy 2014; 4(1): 5-15.

Book Chapters

Turner RB, Schwartz J. Advances in the diagnosis and treatment of infective endocarditis. In: Malhotra A, Ed.

Emerging Applications, Perspectives, and Discoveries in Cardiovascular Research. Accepted.

Turner RB, Schwartz J. Case 137: Osteomyelitis and Septic Arthritis. In: Schwinghammer TL, Ed.

Pharmacotherapy Casebook: A Patient-Focused Approach. 10th edition, McGraw-Hill Education: New York, NY:

2016.

Jordan J, Turner RB, Woo TM. Chapter 24: Drugs Used in Treating Infectious Diseases. In: Woo TM Ed.

Pharmacotherapeutics for Nurse Practitioner Prescribers. 4th Edition, FA Davis Company: Philadelphia, PA.

Research Poster Presentations

Bradley B, Turner RB, Saito E, Doyle I, Copper-DeHoff R. MeRIT Project: Impact of standard of care

implementation on prescriber adoption of opiate MED recommendation in a federally qualified health center

[abstract]. 2017 American College of Clinical Pharmacy Virtual Poster Symposium: May 2017.

Plechot K, Wilson E, Elbarbry F, Turner RB. Pharmacokinetic and Pharmacodynamic Properties of

Vancomycin in Various Pediatric Populations [abstract]. 2017 Annual Seminar: Oregon Society of Health-

System Pharmacists: April 2017.

Bradley B, Turner RB, Saito E, Doyle I, Copper-DeHoff R. MeRIT Project: Impact of standardized vs minimal

education on prescriber adoption of opiate standard of care in a federally qualified health center [abstract].

2016 American College of Clinical Pharmacy Annual Meeting, Hollywood, FL: October 2016.

Steele K, Begert J, McElravey J, Turner RB, Marcus K. Impact of clinical pharmacy spirometry service for

COPD management on patient outcomes compared to usual care [abstract 235479]. 51st Midyear Clinical

Meeting, American Society of Health-System Pharmacists, Las Vegas, NV: December 2016.

Stalvey K, Turner RB. Risk factors associated with surgical site infection in pediatric cardiac surgery patients

who require delayed sternal closure [abstract 5a-236]. 51st Midyear Clinical Meeting, American Society of

Health-System Pharmacists, Las Vegas, NV: December 2016.

Saedi-Kwon H, Schwartz J, Turner RB. Incidence of neutropenia with long-term ceftaroline therapy [abstract

5a-190]. 51st Midyear Clinical Meeting, American Society of Health-System Pharmacists, Las Vegas, NV:

December 2016.

4

Lalikian K, Parsiani R, Turner RB. Use of ceftaroline in osteomyelitis patients with complicated methicillin-

resistant Staphylococcus aureus [abstract 5a-061]. 51st Midyear Clinical Meeting, American Society of Health-

System Pharmacists, Las Vegas, NV: December 2016.

Benabe J, Bradley B, Turner RB. Impact of pharmacist performed screening on the diagnosis of depression in

diabetic patients [241682]. 51st Midyear Clinical Meeting, American Society of Health-System Pharmacists,

Las Vegas, NV: December 2016.

Jacobson S, Esber Z, Turner RB, Bowman MC. Comparison of treatment outcomes between minocycline,

trimethoprim-sulfamethoxazole, and fluoroquinolone monotherapy for Stenotrophomonas maltophilia

infections [abstract 2028]. IDWeek 2016, New Orleans, LA: October 2016.

Stalvey K, Murray JW, Turner RB. Use of cidofovir in patients receiving extracorporeal membrane

oxygentation (ECMO) for severe adenovirus pneumonia: a case report and review of the literature [abstract

5A-241]. 50th Midyear Clinical Meeting, American Society of Health-System Pharmacists, New Orleans, LA:

December 2015.

Hoff M, Turner RB. Ketamine for intractable cancer pain: a case report and policy development [abstract 5A-

234]. 50th Midyear Clinical Meeting, American Society of Health-System Pharmacists, New Orleans, LA:

December 2015.

Turner RB, Valcarlos E, Won R. Impact of infectious diseases consultation and polymerase chain reaction on

clinical outcomes of Staphylococcus aureus bacteremia at a community health system [abstract S-896]. 55th

Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA: September 2015.

Chavez B, Turner RB, Hughes J, Wegrzyn N, Fortner J, Fuentes D. The progression of electronic health record

implementation into a pharmacy curriculum [abstract]. Monash University International Pharmacy Education

Symposium, Prata, Italy: July 2015.

Bath S, Turner RB, Lines J, Malhotra A, Loeffler A. Impact of standardization of duration of antibiotic

prophylaxis for prevention of surgical site infections in pediatric cardiac surgery. [podium] 55th Interscience

Conference on Antimicrobial Agents and Chemotherapy, September 2015, San Diego, CA.

Chavez B, Turner RB, Wegrzyn N, Bradley B, Marcus K. Implementation of a simulated electronic health

record in a PharmD program: successes and challenges [abstract]. AACP Annual Meeting, Washington DC: July

2015.

Rizzo C, Patel R, Jordan J, Turner RB. Incidence of mortality for Staphylococcus aureus bacteremia and

opportunities for antimicrobial stewardship interventions at a community-based teaching health-system

[abstract 2-356]. 49th Midyear Clinical Meeting, American Society of Health-System Pharmacists, Anaheim,

CA: December 2014.

Trang L, Ta M, Turner RB. Duration of therapy guideline: Impact on antibacterial utilization [abstract 2-362].

49th Midyear Clinical Meeting, American Society of Health-System Pharmacists, Anaheim, CA: December 2014.

Bath S, Lines J, Loeffler A, Turner RB. Retrospective evaluation of duration of antibiotic prophylaxis in

preventing surgical site infections in pediatric cardiac surgery [abstract 2-341]. 49th Midyear Clinical Meeting,

American Society of Health-System Pharmacists, Anaheim, CA: December 2014.

Brazeal T, Battles G, Wegrzyn N, Erickson J, Turner RB, Marcus K. Effects on ASCVD risk score in a student-

run hypertension monitoring program [abstract 2-343]. 49th Midyear Clinical Meeting, American Society of

Health-System Pharmacists, Anaheim, CA: December 2014.

Turner RB, Cumpston A, Sweet M, Briggs F, Slain D, Wen S, Craig M, Hamadani M, Petros W. A Prospective,

Controlled Study of Acyclovir Pharmacokinetics in Obese Patients [abstract A-707]. 54th Interscience

Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Washington DC:

September 2014.

5

Turner RB, Cummiskey B, Kojiro K, Chang E, Michaels A. Vancomycin Pharmacokinetics in Adult Patients

Receiving Extracorporeal Membrane Oxygenation [A-1313]. 54th Interscience Conference on Antimicrobial

Agents and Chemotherapy, American Society of Microbiology, Washington DC: September 2014.

Loeffler AM, Valcarlos E, Turner RB, Little M, Gilbert M. Antimicrobial Stewardship Pilot Project at Randall

Children’s Hospital. [podium] 5th Annual International Pediatric Antimicrobial Stewardship Conference,

Pediatric Infectious Diseases Society; Kansas City, MO: June 2014.

Turner RB, Biondo L, Slain D, Phillips U, Cardenas S, Moffett K. A Randomized Pilot Study of Continuous

Versus Intermittent Infusion Piperacillin-Tazobactam for the Treatment of Pulmonary Exacerbations in

Patients with Cystic Fibrosis [abstract 332]. Annual North American Cystic Fibrosis Conference, Salt Lake City,

UT: October 2013.

Turner RB, Biondo L. Twice Daily Dosing of Tobramycin Improves Attainment of Pharmacokinetic

Parameters in Pediatric Patients with Cystic Fibrosis [abstract 333]. Annual North American Cystic Fibrosis

Conference, Salt Lake City, UT: October 2013.

Kirk H, Turner RB, Sweet M, LaSala PR, Slain D, Khakoo R. Comparison of Methicillin-Resistant

Staphylococcus aureus Contamination Rates of Medication Cabinets Between Isolation and Non-Isolation

Rooms [abstract 1690]. IDWeek 2013, San Francisco, CA: October 2013.

Turner RB, Keller L, Slain D, Petros K, Sarwari A. Prolonged Infusion of Cephalosporins Did Not Improve

Outcomes in Gram-Negative Infections in the Clinical Setting [abstract K-718]. 53rd Interscience Conference

on Antimicrobial Agents and Chemotherapy, American Society of Microbiology, Denver, CO: September 2013.

Pontore K, Palmer V, Turner RB, Keller L, Sager R. Assessment of Ciprofloxacin, Levofloxacin, and

Meropenem Use at a Teaching Hospital [abstract 4-440]. 47th Midyear Clinical Meeting, American Society of

Health-System Pharmacists, Las Vegas, NV: December, 2012.

Turner RB, Keller L, Slain D. Treatment of Vancomycin-Resistant Enterococci (VRE) Isolated from Urinary

Samples [abstract 9-259]. 47th Midyear Clinical Meeting, American Society of Health-System Pharmacists, Las

Vegas, NV: December 2012.

Turner RB, Petros K. Ceftazidime usage and dosing at an academic medical center: is a switch to prolonged

infusion merited? [abstract]. 46th Midyear Clinical Meeting, American Society of Health-System Pharmacists,

New Orleans, LA: December 2011.

Turner RB, Morris L, Mehta A, Chi L, Heemer R. Anticoagulation assessment by student pharmacists: clinical

experience as an adjunct to didactic coursework [abstract 1-146]. 45th Midyear Clinical Meeting, American

Society of Health-System Pharmacists, Anaheim, CA: December 2010.

Dahl NJ, Turner RB, Kahaleh A, Bell H. Impact of pharmacists in primary care disease prevention and

treatment: a physician survey of use and acceptance in the health care community [abstract 1-145]. 45th

Midyear Clinical Meeting, American Society of Health-System Pharmacists, Anaheim, CA: December 2010.

Chinikailo M, Kurdelchuk O, Turner RB, Devi SS. Assessment of poison control centers’ current guidelines on

acetaminophen toxicity treatment management [abstract]. Annual Spring Meeting, Allegheny-Erie Society of

Toxicology, Pittsburgh, PA: April 2010.

Turner RB, Vroman B, Ulisse C, Mehta A, Corso T, Devi SS. Primed mice are protected from liver injury

following a normally lethal dose of acetaminophen [abstract]. Annual Spring Meeting, Allegheny-Erie Society

of Toxicology, Pittsburgh, PA: April 2010.

Turner RB, Reist E, Carine A, Spencer J, Kahaleh A. Medication therapy management in ambulatory care

settings: an opportunity for pharmacy students [abstract 5-026]. 44th Midyear Clinical Meeting, American

Society of Health-System Pharmacists, Las Vegas, NV: December 2009.

6

Carine A, Reist E, Turner RB, Spencer J, Kahaleh A. Smokeless tobacco cessation: evidence-based

recommendations [abstract 5-030]. 44th Midyear Clinical Meeting, American Society of Health-System

Pharmacists, Las Vegas, NV: December 2009.

Turner RB, Vroman B, Corso T, Devi SS. Autoprotection model in female mice using acetaminophen as a

model hepatotoxicant [abstract]. Annual Fall Meeting, Allegheny-Erie Society of Toxicology, Pittsburgh, PA:

October 2009.

Turner RB, Vroman B, Corso T, Devi SS. Establishment of acetaminophen autoprotection in mice: a model of

hepatic protection [abstract]. Annual Research Day, Lake Erie College of Osteopathic Medicine, Erie, PA:

October 2009.

Turner RB, Devi SS. Prior exposure of a lower dose of acetaminophen increases survival of mice from

subsequent exposure to an ordinarily lethal dose [abstract]. Annual Spring Meeting, Allegheny-Erie Society of

Toxicology, Morgantown, WV: May 2009.

Residency Project Preceptorship

Phan F, Kojiro K, Turner RB. Heparin versus bivalirudin for anticoagulation in patients requiring

extracorporeal membrane oxygenation. Northwestern States Regional Pharmacy Residency Conference,

Portland, OR: May 2017.

Steele K, Begert J, McElravey J, Turner RB, Marcus K. Impact of clinical pharmacy spirometry service for

COPD management on patient outcomes compared to usual care [abstract 235479]. 51st Midyear Clinical

Meeting, American Society of Health-System Pharmacists, Las Vegas, NV: December 2016.

Benabe J, Bradley B, Turner RB. Impact of pharmacist performed screening on the diagnosis of depression in

diabetic patients [241682]. 51st Midyear Clinical Meeting, American Society of Health-System Pharmacists,

Las Vegas, NV: December 2016.

Phan HV, Deines S, Marcus K, Reta A, Turner RB. Evaluation of the loss of A1C control in patients switched

from insulin glargine to insulin detemir due to formulary change at a federally-qualified health center. 51st

Midyear Clinical Meeting, American Society of Health-System Pharmacists, Las Vegas, NV: December 2016.

Wenzel A, Chan D, Turner RB. Impact of urinalysis with reflex to culture on asymptomatic bacteriuria

[abstract 91]. Presented at the Western States Conference for Pharmacy Residents, Fellows, and Preceptors,

San Diego, CA: May 2016.

Sears B, Turner RB, Chan D. Impact of bacterial rapid identification without antimicrobial stewardship

[abstract 93]. Presented at the Western States Conference for Pharmacy Residents, Fellows, and Preceptors,

San Diego, CA: May 2016.

Grants

Oral vancomycin for prevention of recurrent Clostridium difficile infection in patients requiring antibiotic

therapy: a randomized, controlled trial

Turner RB, Chan D, Won R, Chang E, Crislip M, Williams S, Root A, Atherton C, Brott J

Legacy Health Office of Philanthropy Research Grant: $111,442

Not funded, 2017

Validation of AUC Calculation for Vancomycin Pharmacokinetic Monitoring (VAM)

Turner RB, Won R, Chang E, Kojiro K, Chan D

Pacific University Research Incentive Grant: $7400

Funded, 2016

7

Effect of Extracorporeal Membrane Oxygenation on Antimicrobial Pharmacokinetics in Critically-Ill Adults

Patients (ECMO-APK)

Turner RB, Chang E, Michaels A, Wanek S, Kojiro K, Grover V, Elbarbry F.

Pacific University Faculty Development Award: $3000

Funded, 2015

Establishing a New Multi-Dimensional Strategy to Improve Pneumococcal Immunization in Western Oregon.

Malhotra A, Doyle I, Bradley B, Turner RB, Zuniga R, Deines S.

Pfizer Independent Grants for Learning and Change: Disparities in Adult Immunizations: $1,000,000

Not funded, 2014

Effect of Body Mass on Acyclovir Pharmacokinetics.

Turner RB, Sweet M, Briggs F, Slain D, Craig M, Hamadani M, Petros W, Cumpston A

West Virginia University Quality Department: $20,000

Funded, 2012

Limited Distribution Publications

Surgical prophylaxis in pediatric cardiac surgery. Prepared for Antimicrobial Stewardship Subcommittee,

Legacy Health System; Portland, Oregon: September 2015.

Vancomycin dosing by area under the curve (AUC). Prepared for Antimicrobial Stewardship Subcommittee,

Legacy Health System; Portland, Oregon: September 2015.

Clinical outcomes of Staphylococcus aureus bacteremia stratified by ID consult and evaluation of rPCR. Prepared

for Antimicrobial Stewardship Subcommittee, Legacy Health System; Portland, Oregon: March 2015.

Cefepime dosing and susceptible-dose-dependent reporting. Prepared for Antimicrobial Stewardship

Subcommittee, Legacy Health System; Portland, Oregon: March 2015.

Bactrim and risk of sudden death; interaction with ACEI or aldosterone antagonist. Prepared for Antimicrobial

Stewardship Subcommittee, Legacy Health System; Portland, Oregon: March 2015.

Ceftolozane/tazobactam (Zerbaxa®) monograph. Prepared for Antimicrobial Stewardship Subcommittee,

Legacy Health System; Portland, Oregon: March 2015.

Ceftazidime/avibactam (Avycaz®) monograph. Prepared for Antimicrobial Stewardship Subcommittee,

Legacy Health System; Portland, Oregon: March 2015.

Oritavancin (Orbactiv®) and dalbavancin (Dalvance®) monographs. Prepared for Antimicrobial Stewardship

Subcommittee, Legacy Health System; Portland, Oregon: March 2015.

Peramivir (Rapivab®) monograph. Prepared for Antimicrobial Stewardship Subcommittee, Legacy Health

System; Portland, Oregon: January 2015.

Prolonged infusion dosing of cefepime, meropenem, and piperacillin-tazobactam. Prepared for Antimicrobial

Stewardship Subcommittee, Legacy Health System; Portland, Oregon: October 2014.

Efficacy of high dose versus standard dose influenza vaccine in adults > 65 years old. Prepared for Antimicrobial

Stewardship Subcommittee, Legacy Health System; Portland, Oregon: October 2014.

Fluoroquinolone Class Review and Formulary Recommendation. Prepared for Pharmacy and Therapeutics

Committee, Legacy Health System; Portland, Oregon: May 2014.

Adult Vancomycin Protocol. Prepared for Pharmacy Services, Legacy Health System; Portland, Oregon: March

2014.

8

Colistin Dosing Protocol. Prepared for Antimicrobial Stewardship Subcommittee, Legacy Health System;

Portland, Oregon: December 2013.

Colistin Dosing Protocol. Prepared for Antimicrobial Stewardship and Formulary Subcommittee, West Virginia

University Healthcare; Morgantown, West Virginia: June 2013.

Bone Marrow Transplant: Diagnostic Viral Panel. Prepared for Bone Marrow Transplant Program, West

Virginia University Healthcare; Morgantown, West Virginia: May 2013.

Emtricitabine, rilpivirine, and tenofovir (Complera®) monograph. Prepared for Antimicrobial Stewardship and

Formulary Subcommittee, West Virginia University Healthcare; Morgantown, West Virginia: October 2012.

Ceftaroline fosamil (Teflaro®) monograph. Prepared for Antimicrobial Stewardship and Formulary

Subcommittee, West Virginia University Healthcare; Morgantown, West Virginia: September 2012.

Prolonged infusion dosing of β-lactam antibiotics. Prepared for pharmacy and medical departments. West

Virginia University Healthcare; Morgantown, West Virginia: January 2012.

Maintenance fluids in the critically ill pediatric population. Prepared for the Pediatric Intensive Care Unit. West

Virginia University Healthcare; Morgantown, West Virginia: November, 2011.

Nafcillin sodium/oxacillin sodium (monograph). Update prepared for Lexi-Comp. Hudson, Ohio: September,

2011.

Prolonged-infusion β-lactams. Prepared for Lexi-Comp. Hudson, Ohio: August, 2011.

Metabolic acidosis and the anion gap. Prepared for nursing newsletter, Hamot Medical Center. Erie,

Pennsylvania: November, 2010.

Health-care reform and pharmacist rights. Letter to United States congressman; cosigned by 225 pharmacy

students from the Lake Erie College of Osteopathic Medicine. Erie, Pennsylvania: September, 2009.

Teaching Experience

Course Coordinator

School of Pharmacy, Pacific University

PHRM 681 Clinical Sciences: Infectious Diseases I 2015-present

PHRM 682 Clinical Sciences: Infectious Diseases II 2015-present

PHRM 758 Research elective 2015-2016

PHRM 656 Independent Study: Management of Cardiovascular 2014-2015

and Infectious Diseases

PHRM 648 Clinical Sciences: Gastrointestinal 2014-2015

PHRM 686 Clinical Sciences: Infectious Diseases III 2013-present

Instructor

School of Pharmacy, Pacific University

PHRM 758 Research elective 2015-2016

PHRM 656 Independent Study: Management of Cardiovascular 2014-2015

and Infectious Diseases

PHRM 648 Clinical Sciences: Gastrointestinal 2013-2015

PHRM 681 Clinical Sciences: Infectious Diseases I 2013-present

PHRM 682 Clinical Sciences: Infectious Diseases II 2013-present

PHRM 683 Clinical Sciences: Pulmonology 2013-present

PHRM 686 Clinical Sciences: Infectious Diseases III 2013-present

PHRM 690 Pharmacy Practice 3 2013-2014

PHRM 692 Pharmacy Practice 4 2013-2015

9

School of Physician Assistant Studies, Pacific University

PA 665 Professional Practice Seminar II 2014-present

West Virginia University

PHAR 701 Pharmaceutical Care Lab I 2011-2012

PHAR 730 Pharmacotherapeutics III 2011-2013

PHAR 735 Pharmaceutical Care Lab V 2011-2013

PHAR 791Y Acute Care Case Studies 2011-2012

PHAR 740 Pharmacotherapeutics IV 2011-2013

Introductory Pharmacy Practice Experience (IPPE) 2011-2013

Continuing Education Presentations

Antimicrobials to Treat Gram-positive organisms July 2016

Infectious Diseases Boot Camp, Legacy Health

Update on Anti-Infectives and Current Concepts in Resistance. 25th Annual May 2013

Alumni Day Seminar, West Virginia University

ACPE: 0072-0000-13-047-L01-P

New IDSA Guidelines on Management of Prosthetic Joint Infections: How Can February 2013

We Help Orthopedics? Pharmacy Clinical Conference, West Virginia University

Healthcare: ACPE: 0072-9999-13-003-L01-P

What’s New in Infectious Diseases at WVUH? Pharmacy Clinical Conference, August 2012

West Virginia University Healthcare: ACPE: 0072-9999-12-073-L01-P

Treatment of Complicated Intra-Abdominal Infections. 7th Annual West June 2012

Virginia Pharmacist Education Conference: Hershey, Pennsylvania:

ACPE: 0554-0000-12-055-L04-P

Evaluation and Interpretation of Microbiology Reports. Pharmacy Clinical May 2012

Conference, West Virginia University Healthcare:

ACPE: 0072-9999-12-049-L04-P

Presentations

Clinical Research Design November 2016

Professional Development Seminar Series, School of Pharmacy, Pacific

University, Hillsboro Oregon

Study Design for Pharmacy Residents September 2016

Providence Pharmacy Residency Program, Providence Health and Services,

Portland Oregon

Risk Factors for Sternal Wound Infections April 2016

Pediatric Cardiac Surgery Case Conference, Randall Children’s Hospital,

Legacy Health, Portland Oregon

I Am a Leader December 2015

Organized by Ashim Malhotra, Armstrong Middle School, Forest Grove Oregon

Pediatric Antimicrobial Stewardship: Broad to Specific December 2015

College of Health Professions Faculty Seminar Series, Pacific University,

Hillsboro Oregon

10

Antimicrobial Stewardship: Experience from a Community Children’s Hospital. March 2014

School of Pharmacy Seminar Series, Pacific University, Hillsboro Oregon

Skin Infections in the Neutropenic Patient. Pharmacy Oncology Forum, West May 2013

Virginia University Healthcare, Morgantown WV

Treatment of Tuberculosis in ESRD. Case Conference, Section of Infectious February 2013

Diseases, School of Medicine, West Virginia University

Management of Fungal Infections: An Anti-Fungal Review. Resident Case February 2013

Conference, West Virginia University Healthcare

Restricting of Fluoroquinolones: Where Can We Make an Impact. Antimicrobial February 2013

Stewardship and Formulary Subcommittee, West Virginia University

Healthcare

Echinocandins: A Class Review. Antimicrobial Stewardship and Formulary February 2013

Subcommittee, West Virginia University Healthcare

Identification and Treatment of ESBL-producing Gram-negative Organisms. February 2013

Antimicrobial Stewardship and Formulary Subcommittee, West Virginia

University Healthcare

Updated ACIP Recommendations for the Pneumococcal Vaccine. January 2013

Antimicrobial Stewardship and Formulary Subcommittee, West Virginia

University Healthcare

Use of Doxycycline in Community-Acquired Pneumonia and Impact on C. difficile December 2012

Infection Rates. Antimicrobial Stewardship and Formulary Subcommittee,

West Virginia University Healthcare

Use of Antimicrobials in Endophthalmitis. Case Conference, Section of November 2012

Infectious Diseases, School of Medicine, West Virginia University

Mechanisms and Implications of Bacterial Resistance to Antimicrobials, November 2012

Resident Case Conference, West Virginia University Healthcare

Treatment of Toxoplasmosis in Pregnancy. Case Conference, Section of September 2012

Infectious Diseases, School of Medicine, West Virginia University

Introduction to Clinical Microbiology and Implications to Practice. August 2012

Resident Case Conference, West Virginia University Healthcare

Therapeutic Drug Monitoring: Anti-Infectives. Medicine Noon Conference, August 2012

School of Medicine, West Virginia University

Use of Procalcitonin as a Diagnostic Tool to Aid in Antimicrobial Stewardship. August 2012

Antimicrobial Stewardship and Formulary Subcommittee, West Virginia

University Healthcare

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis. Cystic Fibrosis June 2012

Clinical Conference, West Virginia University Healthcare

Ceftazidime or Cefepime for Treatment of Pseudomonas aeruginosa: May 2012

Intermittent versus Prolonged Infusion. 31st Annual Eastern States Residency

Conference, abstract [78v]: Hershey, Pennsylvania

Prolonged Infusion β-lactam Antibiotics for Treatment of Pulmonary May 2012

Exacerbations of Cystic Fibrosis. Cystic Fibrosis Grand Rounds, West Virginia

University Healthcare

11

Diagnosis and Management of Neutropenic Enterocolitis. Pharmacy Oncology May 2012

Forum, West Virginia University Healthcare

Levofloxacin Inhalation Solution in Cystic Fibrosis. Pharmacy Education, September 2011

Lexi-Comp Inc.: Hudson, Ohio

Cross-Reactivity of Sulfonamide and Other Commonly Prescribed Drugs. April 2011

Physician Education, Group Health: Olympia, Washington

Management of Skin and Soft-Tissue Infections. Pharmacy Education, School March 2011

of Pharmacy, Lake Erie College of Osteopathic Medicine

Diagnosis and Treatment of Legionnaires Disease. Pharmacy Education, December 2010

Saint Vincent Health Center: Erie, Pennsylvania

Licensure and Certification

Oregon Pharmacist License 2013

License #RPH-0013610

Antimicrobial Stewardship Certificate 2013

Society of Infectious Diseases Pharmacists

Scholarship of Teaching Certificate 2012

West Virginia University

West Virginia Board Approved Pharmacist Immunization Certification 2011

West Virginia Pharmacist License 2011

License #RP0007720

American Heart Association: Advanced Cardiac Life Support (ACLS) certified 2011, 2014

American Heart Association: Basic Life Support (BLS) certified 2009, 2011, 2013

Honors and Awards

2016 AACP Teacher of the Year 2016

Pacific University, School of Pharmacy: Hillsboro, Oregon

P2 Student Choice Award 2015-2016 2016

Pacific University, School of Pharmacy: Hillsboro, Oregon

ICAAC Infectious Diseases Fellow Grant Program 2013

American Society for Microbiology, ICAAC: Denver, Colorado

Dean’s Award 2011

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

Academic Excellence Scholarship 2009, 2010

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

American Association of Colleges of Pharmacy Wal-Mart Scholar 2010

American Association of Colleges of Pharmacy: Alexandria, Virginia

American Society of Health-System Pharmacists Student Leadership 2010

Award

American Society of Health-System Pharmacists: Bethesda, Maryland

12

Best Overall Poster 2009

Autoprotection model in female mice using acetaminophen as a model

hepatotoxicant. Presented at the Annual Fall Meeting, Allegheny-Erie Society

of Toxicology: Pittsburgh, Pennsylvania

Second Prize for Scientific Excellence 2009

Establishment of acetaminophen autoprotection in mice: a model of hepatic

protection. Presented at the Lake Erie College of Osteopathic Medicine

Day: Erie, Pennsylvania

Academic Excellence Scholarship 2001, 2002, 2006, 2007

Brigham Young University: Provo, Utah

Committee and Professional Service

Pacific University

University

Faculty Senator to the University, College of Health Professions 2016-2020

University Diversity Committee Member 2014-2015

School of Pharmacy

Curriculum Committee Past-Chair 2016-2017

Curriculum Committee Chair 2015-2016

AACP House of Delegates, Faculty alternate 2015-2016

Student Progression Committee Member 2013-2015

Admissions Committee Member 2013-2014

Society of Infectious Diseases Pharmacists

Antimicrobial Stewardship Committee 2016-2017

Political Advocacy Committee 2013 – 2014, 2015-2016

Community Antimicrobial Stewardship Taskforce 2014-2015

American College of Clinical Pharmacy

ACCP Infectious Diseases Practice Research Network Research Committee 2016-2017

Citywide Pharmacy Residency Major Project 2013-2016

Peer reviewer: Portland, Oregon

Practice Advancement Initiatives Advisory Group 2012-2013

Member, American Society of Health-System Pharmacists: Bethesda, Maryland

Milan Puskar Health Right Clinic 2011-2013

Volunteer pharmacist, free clinic: Morgantown, West Virginia

West Virginia University

Antimicrobial Stewardship and Formulary Subcommittee Member 2012-2013

ASHP Clinical Skills Competition: local competition, judge 2012

Pharmacy, Nutrition, and Therapeutics (PNT) Committee Member 2011-2013

Medication Use Evaluation Subcommittee of PNT Member 2011-2013

Formulary Review Subcommittee of PNT Member 2011-2012

Policy and Legislative Advocacy Advisory Group Member 2010-2011

American Society of Health-System Pharmacists: Bethesda, Maryland

Student Society of Health-System Pharmacists President 2009-2010

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

13

Professional Memberships

Infectious Diseases Society of America 2016-present

Society of Infectious Diseases Pharmacists 2012-present

American College of Clinical Pharmacy 2011-present

American Association of Colleges of Pharmacy 2013-2017

Oregon Society of Health-System Pharmacists 2013-2016

American Society for Microbiology 2012-2017

West Virginia Society of Health-System Pharmacists 2011-2013

Rho Chi: Gamma Tau Chapter 2010-present

Lake Erie College of Osteopathic Medicine: Erie, Pennsylvania

American Society of Health-System Pharmacists 2009-2013

Professional Journal Reviewer

Annals of Pharmacotherapy 2016-present

Journal of Antimicrobial Chemotherapy 2015-present

Journal of Clinical Pharmacy and Therapeutics 2015-present

Antibiotics 2013-present

Journal of Pharmacy and Pharmacology 2013-present

International Journal of Infectious Diseases 2013-present

Pharmacist’s Letter 2013-present